Elite Pharmaceuticals (ELTP) Non Operating Income (2009 - 2026)
Elite Pharmaceuticals (ELTP) reported Non Operating Income of $9.82 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 31.3% from $7.48 million a year earlier.
Elite Pharmaceuticals (ELTP) Non Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Elite Pharmaceuticals' Non Operating Income came in at $32.49 million; for FY2026 (ended Mar 31, 2026), it came in at $7.7 million.
- Non Operating Income has a five-year compound annual growth rate of 30.4% (FY2021 to FY2026).
- By fiscal year, Non Operating Income came in at -$19.65 million in FY2025, -$10.33 million in FY2024, $309,872 in FY2023 (-74.9%) and $1.23 million in FY2022 (-39.5%).
- Five-year quarterly Non Operating Income spans a low of -$22.26 million in fiscal Q1 2026 and a high of $11.82 million in fiscal Q3 2026.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $187,261 (Q1 2027), $10.67 million (Q4 2026) and $11.82 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 9.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.82 Mn |
| Jun 30, 2026 | 187,261.00 |
| Mar 31, 2026 | 10.67 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | -22.26 Mn |
| Mar 31, 2025 | 8.12 Mn |
| Dec 31, 2024 | -11.75 Mn |
| Sep 30, 2024 | -13.00 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | -305,263.00 |
| Mar 31, 2023 | -469,164.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 445,609.00 |
| Jun 30, 2022 | -716,801.00 |
| Mar 31, 2022 | -163,376.00 |
| Dec 31, 2021 | 452,113.00 |
Elite Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();